Saijo Masayuki, Qing Tang, Niikura Masahiro, Maeda Akihiko, Ikegami Tetsuro, Sakai Koji, Prehaud Christophe, Kurane Ichiro, Morikawa Shigeru
Special Pathogens Laboratory, Department of Virology 1. AIDS Research Center, National Institute of Infectious Diseases, Gakuen 4-7-1, Musashimurayama, Tokyo 208-0011, Japan.
J Clin Microbiol. 2002 Feb;40(2):372-5. doi: 10.1128/JCM.40.2.372-375.2002.
A HeLa cell line continuously expressing recombinant nucleoprotein (rNP) of the Crimean-Congo hemorrhagic fever virus (CCHFV) was established by transfection with an expression vector containing the cDNA of CCHFV NP (pKS336-CCHFV-NP). These cells were used as antigens for indirect immunofluorescence (IF) to detect immunoglobulin G antibodies to CCHFV. The sensitivity and specificity of this IF technique were examined by using serum samples and were compared to those of the IF technique using CCHFV-infected Vero E6 cells (authentic antigen). Staining of the CCHFV rNP expressed in HeLa cells showed a unique granular pattern similar to that of CCHFV-infected Vero E6 cells. Positive staining could easily be distinguished from a negative result. All 13 serum samples determined to be positive by using the authentic antigen were also determined to be positive by using CCHFV rNP-expressing HeLa cells (recombinant antigen). The 108 serum samples determined to be negative by using the authentic antigen were also determined to be negative by using the recombinant antigen. Thus, both the sensitivity and the specificity of this IF technique were 100% compared to the IF with authentic antigen. The novel IF technique using CCHFV rNP-expressing HeLa cells can be used not only for diagnosis of CCHF but also for epidemiological studies on CCHFV infections.
通过用含有克里米亚-刚果出血热病毒(CCHFV)核蛋白(NP)cDNA的表达载体(pKS336-CCHFV-NP)转染,建立了持续表达CCHFV重组核蛋白(rNP)的HeLa细胞系。这些细胞用作间接免疫荧光(IF)的抗原,以检测针对CCHFV的免疫球蛋白G抗体。使用血清样本检测了这种IF技术的敏感性和特异性,并与使用CCHFV感染的Vero E6细胞(真实抗原)的IF技术进行了比较。HeLa细胞中表达的CCHFV rNP染色显示出与CCHFV感染的Vero E6细胞相似的独特颗粒模式。阳性染色很容易与阴性结果区分开来。使用真实抗原确定为阳性的所有13份血清样本,使用表达CCHFV rNP的HeLa细胞(重组抗原)时也被确定为阳性。使用真实抗原确定为阴性的108份血清样本,使用重组抗原时也被确定为阴性。因此,与使用真实抗原的IF相比,这种IF技术的敏感性和特异性均为100%。使用表达CCHFV rNP的HeLa细胞的新型IF技术不仅可用于CCHF的诊断,还可用于CCHFV感染的流行病学研究。